159 related articles for article (PubMed ID: 10231471)
1. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients.
Vychytil A; Födinger M; Papagiannopoulos M; Wölfl G; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 May; 55(5):2054-61. PubMed ID: 10231471
[TBL] [Abstract][Full Text] [Related]
2. [Hyperhomocysteinemia in CAPD patients: peritoneal transport of total homocysteine at peritoneal equilibration test and daily elimination of total homocysteine].
Hirose S; Kono R; Mitarai T; Isoda K; Kim S; Shimoyama H
Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):778-86. PubMed ID: 10655726
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
4. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
[TBL] [Abstract][Full Text] [Related]
5. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
Moustapha A; Gupta A; Robinson K; Arheart K; Jacobsen DW; Schreiber MJ; Dennis VW
Kidney Int; 1999 Apr; 55(4):1470-5. PubMed ID: 10201012
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
[TBL] [Abstract][Full Text] [Related]
8. [Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients: effects on unsaturated fatty acids].
Hirose S; Kim S; Matsuda A; Itakura Y; Matsumura O; Tamura H; Nagasawa R; Mitarai T; Isoda K
Nihon Jinzo Gakkai Shi; 1998 Jan; 40(1):8-16. PubMed ID: 9513377
[TBL] [Abstract][Full Text] [Related]
9. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
11. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
[TBL] [Abstract][Full Text] [Related]
12. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
13. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.
Vychytil A; Födinger M; Wölfl G; Enzenberger B; Auinger M; Prischl F; Buxbaum M; Wiesholzer M; Mannhalter C; Hörl WH; Sunder-Plassmann G
Kidney Int; 1998 Jun; 53(6):1775-82. PubMed ID: 9607212
[TBL] [Abstract][Full Text] [Related]
14. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in peritoneal dialysis patients.
Jovanović N; Božinovski SŽ; Krstić S; Obrenović R; Trbojević-Stanković J; Stojimirović B
Clin Lab; 2014; 60(10):1695-701. PubMed ID: 25651716
[TBL] [Abstract][Full Text] [Related]
16. Dialysance of adrenocorticoids during continuous ambulatory peritoneal dialysis.
Zager PG; Spalding CT; Frey HJ; Brittenham MC; Nevarez M
J Clin Endocrinol Metab; 1988 Jul; 67(1):110-5. PubMed ID: 3379127
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients.
Sezer S; Elsurer R; Afsar B; Arat Z; Ozdemir NF; Haberal M
Nephron Clin Pract; 2007; 107(4):c156-62. PubMed ID: 17957127
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis.
De Vecchi AF; Catena FB; Accinni R; Patrosso C
Kidney Int; 1999 Oct; 56(4):1604-5. PubMed ID: 10610417
[No Abstract] [Full Text] [Related]
19. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.
Yang X; Zhang H; Hang Y; Yan H; Lin A; Huang J; Ni Z; Qian J; Fang W
Am J Nephrol; 2014; 39(6):459-65. PubMed ID: 24854010
[TBL] [Abstract][Full Text] [Related]
20. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]